Journal News

MCP: When mitochondria make B cells go bad

John Arnst
Feb. 1, 2018

B-cell chronic lymphocytic leukemia, or B-CLL, is the most common type of leukemia in adults and primarily affects elderly patients. The disease results from a patient’s bone marrow overproducing immature lymphocytes, a form of white blood cells that fight infections less effectively than their healthy counterparts but survive longer, ultimately overwhelming them and spreading unchecked. Unlike acute leukemia, B-CLL can take several years to cause problems for a patient, but it is less responsive to chemotherapy.

When mitochondria, highlighted here in cow cells, suffer age-related oxidative damage, they can give rise to chronic lymphocytic leukemia.courtesy of Torsten Wittmann, University of California, San Francisco

While novel treatments have been developed in recent years, they only target the B cells once they’ve mutated to an immature, cancerous state. To develop treatments for B-CLL that might prevent B cells from becoming cancerous in the first place, researchers led by Christopher Gerner at the University of Vienna and Vienna Metabolomics Center have performed a comprehensive proteomics analysis of B-CLL cells and mature B cells in young and elderly patients. They described their work in a paper in the journal Molecular & Cellular Proteomics.

“It could be nice to not only target the cancer cells, but those cells prone to becoming cancer cells,” Gerner said. “What we actually saw when we compared the young and the elderly donors was a very clear signature of mitochondrial stress and metabolic stress.”

Gerner and colleagues found that B-CLL cells have an increased expression of stem cell-associated molecules and a reduced expression of tumor-suppressing molecules and stress-related serotonin transporters as well as an observed increase in glutamine consumption and beta-oxidation of fatty acid.

This indicated that reactive oxidative species, which are carcinogenic and cause damage to cells, were being upregulated, Gerner said, which would explain why the incidence of mutations that lead to B-CLL increases with age. The researchers hope that the alterations in regulation also may provide a proteomic signature for immunosenescence, the immune system’s natural weakening with age.

Gerner and his fellow researchers plan to continue this research by performing their proteomic analysis on blood samples taken from greater numbers of healthy elderly people and B-CLL patients to ultimatelybe able to test when mitochondria have become predisposed for the disease.

“The pressure on those cells was simply different … and this pressure is something I would like to detect and measure in patients,” Gerner said. “That would be the ultimate aim.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
John Arnst

John Arnst was a science writer for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Predicting fatty liver disease from a tiny blood sample
Journal News

Predicting fatty liver disease from a tiny blood sample

Dec. 24, 2024

Obesity and being overweight aren't the only factors that contribute to liver disease. New tests can help identify who is at risk or already has the disease, even in people who are lean or have a normal weight.

An ancient animal helps scientists improve modern technology
News

An ancient animal helps scientists improve modern technology

Dec. 22, 2024

The same molecules that help tardigrades survive extreme weather can improve cryo-EM images of cellular structures and proteins, a team led by University of Wisconsin–Madison researcher Ci Ji Lim reports.

New structure gives insight into mRNA export and cancers
News

New structure gives insight into mRNA export and cancers

Dec. 21, 2024

Yi Ren’s lab at Vanderbilt has described the structure of a protein complex that sheds light on the underlying molecular mechanism of mRNA export.

Analyzing triglycerides in Americans of African ancestry
Journal News

Analyzing triglycerides in Americans of African ancestry

Dec. 19, 2024

Using the All of Us database, researchers at Vanderbilt sought a genetic reason why some patients, often underrepresented in research, could have varying levels of fat in the bloodstream.

Of yeasts and men: One-hour proteomes, 10 years apart
Journal News

Of yeasts and men: One-hour proteomes, 10 years apart

Dec. 17, 2024

To profile the human genome within an hour, the researchers used a new mass spectrometer and packed their liquid chromatography columns with very high pressure.

Cells have more mini ‘organs’ than researchers thought
News

Cells have more mini ‘organs’ than researchers thought

Dec. 15, 2024

Membraneless organelles, also called biomolecular condensates, are changing how scientists think about protein chemistry, various diseases and even the origin of life.